Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Expression of p16(Ink4a) and p19(Arf) increases with age in both rodent and human tissues. However, whether these tumour suppressors are effectors of ageing remains unclear, mainly because knockout mice lacking p16(Ink4a) or p19(Arf) die early of tumours. Here, we show that skeletal muscle and fat, two tissues that develop early ageing-associated phenotypes in response to BubR1 insufficiency, have high levels of p16(Ink4a) and p19(Arf). Inactivation of p16(Ink4a) in BubR1-insufficient mice attenuates both cellular senescence and premature ageing in these tissues. Conversely, p19(Arf) inactivation exacerbates senescence and ageing in BubR1 mutant mice. Thus, we identify BubR1 insufficiency as a trigger for activation of the Cdkn2a locus in certain mouse tissues, and demonstrate that p16(Ink4a) is an effector and p19(Arf) an attenuator of senescence and ageing in these tissues.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consistent with this idea is the observation that interference with senescent cell accumulation in BubR1 progeroid mice delays several aging-associated disorders that these animals develop 4 , 5 .”
From Naturally occurring p16Ink4a-positive cells shorten healthy lifespan (2016) · cites this paper as [5]
In the citing paper
“In the absence of p16, the age-related deterioration of adipose tissue, skeletal muscle and eye was attenuated193.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [193]
In the citing paper
“Importantly, genetically preventing the accumulation of p19ARF, a tumour suppressor that modulates the stability of p53 by influencing MDM2-mediated destruction, did not result in similar prevention193, indicating that p16 was critical for these disorders.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [193]
In the citing paper
“Removal of SnCs delays several pathologies7–9 and increases healthy lifespan8.”
From Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment (2017) · cites this paper as [9]
In the citing paper
“Remarkably, treated mice of both BubR1H/H;INK-ATTAC lines had substantially delayed onset of lordokyphosis (a measure of sarcopenia onset in this model15) and cataracts compared to untreated mice (Fig. 2b, c).”
From Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders (2011) · cites this paper as [15]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Vousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,272
Cellular senescence in cancer and aging.
Collado, M., Blasco, M. A., & Serrano, M. (2007) · Cell · doi:10.1016/j.cell.2007.07.003 · Cited by 1,708
Ink4a/Arf expression is a biomarker of aging
Krishnamurthy, J., Torrice, C., Ramsey, M. R., Kovalev, G. I., Al-Regaiey, K., Su, L., & Sharpless, N. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22475 · Cited by 1,486
Kondratov, R. V., Kondratova, A. A., Gorbacheva, V. Y., Vykhovanets, O. V., & Antoch, M. P. (2006) · Genes & Development · doi:10.1101/gad.1432206 · Cited by 1,188
Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a
Janzen, V., Forkert, R., Fleming, H. E., Saito, Y., Waring, M. T., Dombkowski, D. M., Cheng, T., DePinho, R. A., Sharpless, N. E., & Scadden, D. T. (2006) · Nature · doi:10.1038/nature05159 · Cited by 1,106
The Regulation of INK4/ARF in Cancer and Aging
Kim, W. Y., & Sharpless, N. E. (2006) · Cell · doi:10.1016/j.cell.2006.10.003 · Cited by 1,009 · cited 1×
“Both p16 Ink4a and p19 Arf are effectors of senescence in cultured cell”
Backgroundp16INK4a induces an age-dependent decline in islet regenerative potential
Krishnamurthy, J., Ramsey, M. R., Ligon, K. L., Torrice, C., Koh, A., Bonner-Weir, S., & Sharpless, N. E. (2006) · Nature · doi:10.1038/nature05092 · Cited by 1,003 · cited 1×
“Recent evidence in middle-aged p16 Ink4a knockout mice indicates that the age-induced expression of p16 Ink4a limits the proliferative and regenerative capacity of progenitor population”
Background
Cited by
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670
Self-citationDNA methylation-based biomarkers and the epigenetic clock theory of ageing
Horvath, S., & Raj, K. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0004-3 · Cited by 3,095
Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876
“Consistent with this idea is the observation that interference with senescent cell accumulation in BubR1 progeroid mice delays several aging-associated disorders that these animals develop 4, 5 .”
Self-citationCellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
The role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623
Cellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363
Self-citationCellular senescence in ageing: from mechanisms to therapeutic opportunities
Di Micco, R., Krizhanovsky, V., Baker, D., & d’Adda di Fagagna, F. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00314-w · Cited by 2,277
Self-citationFour faces of cellular senescence
Rodier, F., & Campisi, J. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009094 · Cited by 2,070
“…which induced widespread cellular senescence and several age-related degenerative pathologies; further, genetic manipulations that attenuated (p16INK4a deficiency) or exacerbated (deficiency in p19ARF) the senescence response also attenuated or exacerbated the pathology (Baker et al., 2008).”
Cellular senescence and the senescent secretory phenotype: therapeutic opportunities
Tchkonia, T., Zhu, Y., van Deursen, J., Campisi, J., & Kirkland, J. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64098 · Cited by 1,774
“The abundance of senescent cells increases in multiple tissues with chronological aging and in progeroid syndromes (43, 47, 50, 52–55).”
Jeon, O. H., Kim, C., Laberge, R.-M., Demaria, M., Rathod, S., Vasserot, A. P., Chung, J. W., Kim, D. H., Poon, Y., David, N., et al. (2017) · Nature Medicine · doi:10.1038/nm.4324 · Cited by 1,515
Self-citationClearance of senescent glial cells prevents tau-dependent pathology and cognitive decline
Bussian, T. J., Aziz, A., Meyer, C. F., Swenson, B. L., van Deursen, J. M., & Baker, D. J. (2018) · Nature · doi:10.1038/s41586-018-0543-y · Cited by 1,289
Self-citationSenescent cells: an emerging target for diseases of ageing
Childs, B. G., Gluscevic, M., Baker, D. J., Laberge, R.-M., Marquess, D., Dananberg, J., & van Deursen, J. M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.116 · Cited by 1,284
Self-citationForging a signature of in vivo senescence
Sharpless, N. E., & Sherr, C. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3960 · Cited by 1,104
Fat tissue, aging, and cellular senescence
Tchkonia, T., Morbeck, D. E., Von Zglinicki, T., Van Deursen, J., Lustgarten, J., Scrable, H., Khosla, S., Jensen, M. D., & Kirkland, J. L. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00608.x · Cited by 1,094
“Importantly, p16Ink4a ablation prevents accumulation of senescent cells in BubR1 hypomorphic mice, implicating p16Ink4a in establishing the senescent phenotype in this model (Baker et al., 2008).”
BackgroundFeedback between p21 and reactive oxygen production is necessary for cell senescence
Passos, J. F., Nelson, G., Wang, C., Richter, T., Simillion, C., Proctor, C. J., Miwa, S., Olijslagers, S., Hallinan, J., Wipat, A., et al. (2010) · Molecular Systems Biology · doi:10.1038/msb.2010.5 · Cited by 1,019
“However, interventions upstream of the cell cycle checkpoint machinery may significantly increase cancer risk (Baker et al, 2008; Tomas-Loba et al, 2008).”
Geriatric muscle stem cells switch reversible quiescence into senescence
Sousa-Victor, P., Gutarra, S., García-Prat, L., Rodriguez-Ubreva, J., Ortet, L., Ruiz-Bonilla, V., Jardí, M., Ballestar, E., González, S., Serrano, A. L., et al. (2014) · Nature · doi:10.1038/nature13013 · Cited by 1,010
Senescence and apoptosis: dueling or complementary cell fates?
Childs, B. G., Baker, D. J., Kirkland, J. L., Campisi, J., & van Deursen, J. M. (2014) · The EMBO Reports · doi:10.15252/embr.201439245 · Cited by 915
“Mice expressing low amounts of the mitotic checkpoint protein BubR1 due to hypomorphic alleles (BubR1) accumulate senescent cells in several tissues early in life [117] and rapidly develop progeroid phenotypes [118].”
Self-citationCellular senescence and its effector programs
Salama, R., Sadaie, M., Hoare, M., & Narita, M. (2014) · Genes & Development · doi:10.1101/gad.235184.113 · Cited by 855
“Of note, Baker et al. (2008, 2011) showed that, in contrast to the case of p16 ablation, which accelerates lung tumor development in the BubR1 hypomorphic background, clearance of p16-expressing senescent cells does not appear to show obvious side effects.”
BackgroundResultBoveri revisited: chromosomal instability, aneuploidy and tumorigenesis
Holland, A. J., & Cleveland, D. W. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2718 · Cited by 859
“For example, reduced levels of BUBR1 promote an increase in lung tumours in mice that lack the p16 tumour suppresso”
BackgroundJurk, D., Wang, C., Miwa, S., Maddick, M., Korolchuk, V., Tsolou, A., Gonos, E. S., Thrasivoulou, C., Jill Saffrey, M., Cameron, K., et al. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00870.x · Cited by 598
“There is increasing evidence for cell senescence as a contributing, potentially causal factor for aging in mammals (Krishnamurthy et al., 2004; Herbig et al., 2006; Choudhury et al., 2007; Baker et al., 2008, 2011; Wang et al., 2009, 2010).”
BackgroundCellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives
Baker, D. J., & Petersen, R. C. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95145 · Cited by 514
“Subsequent studies using the INK-ATTAC model determined that senescent cells drive various natural age-related pathologies, shorten life, and promote the age-associated diseases atherosclerosis and osteoarthritis (20, 29–31).”
Self-citationExpression of p16 INK4a in peripheral blood T‐cells is a biomarker of human aging
Liu, Y., Sanoff, H. K., Cho, H., Burd, C. E., Torrice, C., Ibrahim, J. G., Thomas, N. E., & Sharpless, N. E. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00489.x · Cited by 509
“Moreover, inactivation of p16INK4a, but not Arf, partially rescues several age-related phenotypes in a progeroid mouse strain (Baker et al., 2008).”
BackgroundInfluentialInside and out: the activities of senescence in cancer
Pérez-Mancera, P. A., Young, A. R. J., & Narita, M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3773 · Cited by 462
The central role of muscle stem cells in regenerative failure with aging
Blau, H. M., Cosgrove, B. D., & Ho, A. T. V. (2015) · Nature Medicine · doi:10.1038/nm.3918 · Cited by 437
Senescence-associated inflammatory responses: aging and cancer perspectives
Lasry, A., & Ben-Neriah, Y. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.009 · Cited by 408
Monitoring Tumorigenesis and Senescence In Vivo with a p16INK4a-Luciferase Model
Burd, C. E., Sorrentino, J. A., Clark, K. S., Darr, D. B., Krishnamurthy, J., Deal, A. M., Bardeesy, N., Castrillon, D. H., Beach, D. H., & Sharpless, N. E. (2013) · Cell · doi:10.1016/j.cell.2012.12.010 · Cited by 419
“…extensive work from our group and others suggesting that age-related phenotypes, including cancer, are promoted by the accumulation senescent cells (Baker et al., 2008, 2011; Bavik et al., 2006; Berent-Maoz et al., 2012; Campisi et al., 2011; Chen et al., 2011; Coppé et al., 2008; Kang et al.,…”
Biomarkers of cellular senescence and skin aging
Wang, A. S., & Dreesen, O. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00247 · Cited by 404
DNA damage checkpoints in stem cells, ageing and cancer
Sperka, T., Wang, J., & Rudolph, K. L. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3420 · Cited by 393
Recurrent turnover of senescent cells during regeneration of a complex structure
Yun, M. H., Davaapil, H., & Brockes, J. P. (2015) · eLife · doi:10.7554/elife.05505 · Cited by 385
Cellular senescence in osteoarthritis pathology
McCulloch, K., Litherland, G. J., & Rai, T. S. (2017) · Aging Cell · doi:10.1111/acel.12562 · Cited by 367
“Key words: cellular senescence; epigenetics; osteoarthritis.”
BackgroundCellular senescence in renal ageing and disease
Sturmlechner, I., Durik, M., Sieben, C. J., Baker, D. J., & van Deursen, J. M. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.183 · Cited by 345
Self-citationHealing and Hurting: Molecular Mechanisms, Functions, and Pathologies of Cellular Senescence
Adams, P. D. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.021 · Cited by 326
Aging and adipose tissue: potential interventions for diabetes and regenerative medicine
Palmer, A. K., & Kirkland, J. L. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.02.013 · Cited by 321
“mune clearance of cells with persistent DNA damage (Baker et al., 2008; Karakasilioti et al., 2013).”
Cellular Senescence in the Kidney
Docherty, M.-H., O’Sullivan, E. D., Bonventre, J. V., & Ferenbach, D. A. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018121251 · Cited by 291
Senescent Cells: A Novel Therapeutic Target for Aging and Age-Related Diseases
Naylor, R. M., Baker, D. J., & van Deursen, J. M. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.193 · Cited by 280
Self-citationIdentification of senescent cell surface targetable protein DPP4
Kim, K. M., Noh, J. H., Bodogai, M., Martindale, J. L., Yang, X., Indig, F. E., Basu, S. K., Ohnuma, K., Morimoto, C., Johnson, P. F., et al. (2017) · Genes & Development · doi:10.1101/gad.302570.117 · Cited by 270
“…have been documented for senescent cells accumulating in tissues of older organisms, as they trigger or exacerbate age-related diseases such as cancer, cataracts, arthritis, and atherosclerosis (Baker et al. 2008, 2011; Prieur and Peeper 2008; Muñoz-Espín and Serrano 2014; van Deursen 2014).”
BackgroundIncreased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan
Baker, D. J., Dawlaty, M. M., Wijshake, T., Jeganathan, K. B., Malureanu, L., van Ree, J. H., Crespo-Diaz, R., Reyes, S., Seaburg, L., Shapiro, V., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2643 · Cited by 246
“Lung tissue (n) Ras (4) T7;Ras (6) % Aneuploidy chrom.”
BackgroundSelf-citationChromosome missegregation rate predicts whether aneuploidy will promote or suppress tumors
Silk, A. D., Zasadil, L. M., Holland, A. J., Vitre, B., Cleveland, D. W., & Weaver, B. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317042110 · Cited by 252
“Multiple other mouse models that develop low CIN (Bub1+/−, Bub1 kinase deficient, BubR1+/−, Bub3+/−, Rae1+/−, Bub3+/−;Rae1+/−, Cdc20+/−, and animals hypomorphic for Separase) have long life expectancies and show no increase in spontaneous tumor development (37, 42, 47–52).”
BackgroundInfluentialINK4/ARF transcript expression is associated with chromosome 9p21 variants linked to atherosclerosis
Liu, Y., Sanoff, H. K., Cho, H., Burd, C. E., Torrice, C., Mohlke, K. L., Ibrahim, J. G., Thomas, N. E., & Sharpless, N. E. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005027 · Cited by 248
“In murine systems, Arf expression and has been shown to exert a general anti-aging effect [31,32], presumably through an enhancement of DNA repair.”
BackgroundMalaquin, N., Martinez, A., & Rodier, F. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.05.010 · Cited by 247
“It is now well documented that senescent cells accumulate in aging tissues, and that their clearance can rescue at least some tissue dysfunctions (Baker et al., 2016; Baker et al., 2008; Baker et al., 2011; Chang et al., 2016; Dimri et al., 1995; Herbig et al., 2006).”
Aging and Regional Differences in Fat Cell Progenitors – A Mini-Review
Sepe, A., Tchkonia, T., Thomou, T., Zamboni, M., & Kirkland, J. L. (2011) · Gerontology · doi:10.1159/000279755 · Cited by 232
“and in fat tissue dysfunction in mice with progeric syndromes induced by DNA-damaging mutations [”
BackgroundLivshits, G., & Kalinkovich, A. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100980 · Cited by 237
Obesity and aging: Molecular mechanisms and therapeutic approaches
Santos, A. L., & Sinha, S. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101268 · Cited by 230
Baker, D. J., Jin, F., Jeganathan, K. B., & van Deursen, J. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.10.023 · Cited by 218
“In vivo BrdU labeling experiments were performed as described elsewhere (Baker et al., 2008).”
MethodSelf-citationSenescent alveolar macrophages promote early-stage lung tumorigenesis
Prieto, L. I., Sturmlechner, I., Graves, S. I., Zhang, C., Goplen, N. P., Yi, E. S., Sun, J., Li, H., & Baker, D. J. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.05.006 · Cited by 212
Self-citationNKG2D-CAR T cells eliminate senescent cells in aged mice and nonhuman primates
Yang, D., Sun, B., Li, S., Wei, W., Liu, X., Cui, X., Zhang, X., Liu, N., Yan, L., Deng, Y., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.add1951 · Cited by 217
Vascular senescence in cardiovascular and metabolic diseases
Katsuumi, G., Shimizu, I., Yoshida, Y., & Minamino, T. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00018 · Cited by 196
β Cell Aging Markers Have Heterogeneous Distribution and Are Induced by Insulin Resistance
Aguayo-Mazzucato, C., van Haaren, M., Mruk, M., Lee, T. B., Crawford, C., Hollister-Lock, J., Sullivan, B. A., Johnson, J. W., Ebrahimi, A., Dreyfuss, J. M., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.03.015 · Cited by 198
Senescent cells: a therapeutic target for cardiovascular disease
Childs, B. G., Li, H., & van Deursen, J. M. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95146 · Cited by 192
“When SNC formation was blunted by genetic deletion of the senescence effector p16Ink4a, development of these degenerative phenotypes was blocked (16).”
BackgroundAdaptations to a Subterranean Environment and Longevity Revealed by the Analysis of Mole Rat Genomes
Fang, X., Seim, I., Huang, Z., Gerashchenko, M. V., Xiong, Z., Turanov, A. A., Zhu, Y., Lobanov, A. V., Fan, D., Yim, S. H., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.030 · Cited by 195
Aneuploidy as a promoter and suppressor of malignant growth
Vasudevan, A., Schukken, K. M., Sausville, E. L., Girish, V., Adebambo, O. A., & Sheltzer, J. M. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00321-1 · Cited by 177
Real-time in vivo imaging of p16Ink4a reveals cross talk with p53
Yamakoshi, K., Takahashi, A., Hirota, F., Nakayama, R., Ishimaru, N., Kubo, Y., Mann, D. J., Ohmura, M., Hirao, A., Saya, H., et al. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200904105 · Cited by 172
“…multiple levels of control (Jacobs et al., 1999; Passegué and Wagner, 2000; Ohtani et al., 2001, 2003; Gonzalez et al., 2006; Bracken et al., 2007; Kotake et al., 2007; Baker et al., 2008; Kia et al., 2008; Agger et al., 2009; Barradas et al., 2009; Tzatsos et al., 2009; Witcher and Emerson, 2009).”
PAI-1–regulated extracellular proteolysis governs senescence and survival in Klotho mice
Eren, M., Boe, A. E., Murphy, S. B., Place, A. T., Nagpal, V., Morales-Nebreda, L., Urich, D., Quaggin, S. E., Budinger, G. R. S., Mutlu, G. M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321942111 · Cited by 176
“BubR1 mice have a shortened average lifespan (24 wk) and develop various aginglike phenotypic abnormalities, including sarcopenia, cataracts, arterial stiffening, and impaired wound healing (14).”
BackgroundSenescence in Wound Repair: Emerging Strategies to Target Chronic Healing Wounds
Wilkinson, H. N., & Hardman, M. J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00773 · Cited by 173
“Senescence is both a characteristic feature of Baker et al. (2013), Xu et al. (2015), and Helman et al. (2016) and contributor to Baker et al. (2008, 2011) widespread tissue ageing.”
BackgroundClinical strategies and animal models for developing senolytic agents
Kirkland, J. L., & Tchkonia, T. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2014.10.012 · Cited by 168
“Progeroid mice that have increased senescent cells include lamin A-mutated, Klotho-deficient, Ercc−−, and BubR1H/H mice (Baker et al., 2008; Chen et al., 2013; Eren et al., 2014b; Tchkonia et al., 2013).”
BackgroundLe, O. N. L., Rodier, F., Fontaine, F., Coppe, J., Campisi, J., DeGregori, J., Laverdière, C., Kokta, V., Haddad, E., & Beauséjour, C. M. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00567.x · Cited by 168
“Similarly, p16 deficiency delays the onset of age-related phenotypes in a mouse model of accelerated aging, providing a direct link for the involvement of this protein in organismal aging (Baker et al., 2008).”
BackgroundInfluentialThe emerging role of alternative splicing in senescence and aging
Deschênes, M., & Chabot, B. (2017) · Aging Cell · doi:10.1111/acel.12646 · Cited by 166
“…for senescence in aging, reducing the level of senescent cells is associated with a significant decrease in the incidence of age-related disorders (Baker et al., 2008, 2011; Zhu et al., 2015), and was shown recently to improve homeostasis and extend lifespan in mouse models (Baker et al., 2016;…”
BackgroundWhole chromosome instability and cancer: a complex relationship
Ricke, R. M., van Ree, J. H., & van Deursen, J. M. (2008) · Trends in Genetics · doi:10.1016/j.tig.2008.07.002 · Cited by 159
Vascular smooth muscle cell senescence and age-related diseases: State of the art
Chi, C., Li, D.-J., Jiang, Y.-J., Tong, J., Fu, H., Wu, Y.-H., & Shen, F.-M. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.08.015 · Cited by 158
Hwang, H. J., Lee, Y.-R., Kang, D., Lee, H., Seo, H. R., Ryu, J., Kim, Y.-N., Ko, Y., Park, H. J., & Lee, J. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.06.019 · Cited by 173
HMGA2, MicroRNAs, and Stem Cell Aging
Hammond, S. M., & Sharpless, N. E. (2008) · Cell · doi:10.1016/j.cell.2008.11.026 · Cited by 168
“Most recently, loss of p16INK4a has been shown to attenuate many complex age-related phenotypes in a progeroid mouse strain that ages prematurely (Baker et al., 2008).”
BackgroundAneuploidy: implications for protein homeostasis and disease
Oromendia, A. B., & Amon, A. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.013391 · Cited by 166
“Recent studies have also unveiled a connection between aneuploidy and aging, specifically that increases in aneuploidy are associated with premature aging and reduced lifespan (Baker et al., 2004; Baker et al., 2008; Wijshake et al., 2012; Baker et al., 2013).”
BackgroundRegenerative decline of stem cells in sarcopenia
Sousa-Victor, P., & Muñoz-Cánoves, P. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.02.002 · Cited by 147
“Interestingly, mutant mice carrying BubR1 hypomorphic alleles show early signs of sarcopenia accompanied by the expression of senescence markers (Baker et al., 2004, 2008).”
Adult-onset, short-term dietary restriction reduces cell senescence in mice
Wang, C., Maddick, M., Miwa, S., Jurk, D., Czapiewski, R., Saretzki, G., Langie, S. A. S., Godschalk, R. W. L., Cameron, K., & von Zglinicki, T. (2010) · Aging · doi:10.18632/aging.100196 · Cited by 142
“High frequencies of senescent cells have been associated with age-related diseases like osteoarthritis and atherosclerosis [29,30] and were also found in mouse models of accelerated aging [31-34].”
BackgroundDiaphragm muscle sarcopenia in aging mice
Greising, S. M., Mantilla, C. B., Gorman, B. A., Ermilov, L. G., & Sieck, G. C. (2013) · Experimental Gerontology · doi:10.1016/j.exger.2013.06.001 · Cited by 141
Experimental Models of Sarcopenia: Bridging Molecular Mechanism and Therapeutic Strategy
Mankhong, S., Kim, S., Moon, S., Kwak, H., Park, D., & Kang, J. (2020) · Cells · doi:10.3390/cells9061385 · Cited by 162
“Previous studies suggested that senescent satellite cells accumulated in skeletal muscles of aged rodents and elderly people by demonstrating the expression of p16Ink4a and positive results of the senescence-associated β-galactosidase assay [8,9], although a recent study demonstrated no expression of p16 Ink4a- and p2…”
BackgroundInflammaging: The ground for sarcopenia?
Liang, Z., Zhang, T., Liu, H., Li, Z., Peng, L., Wang, C., & Wang, T. (2022) · Experimental Gerontology · doi:10.1016/j.exger.2022.111931 · Cited by 167
Role of the inflammation-autophagy-senescence integrative network in osteoarthritis
Vinatier, C., Domínguez, E., Guicheux, J., & Caramés, B. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00706 · Cited by 135
“On the other hand, senescence exerts detrimental actions through its promoting effect in aging and age-related diseases as evidenced by the accumulation of senescent cells in degenerated tissues (Baker et al., 2008; Campisi, 2014) and the exponential increase in the expression of some senescent markers thereby suggest…”
BackgroundLozano-Torres, B., Estepa-Fernández, A., Rovira, M., Orzáez, M., Serrano, M., Martínez-Máñez, R., & Sancenón, F. (2019) · Nature Reviews Chemistry · doi:10.1038/s41570-019-0108-0 · Cited by 140
Elevated Local Senescence in Diabetic Wound Healing Is Linked to Pathological Repair via CXCR2
Wilkinson, H. N., Clowes, C., Banyard, K. L., Matteuci, P., Mace, K. A., & Hardman, M. J. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.01.005 · Cited by 142
Cancer and Aging - the Inflammatory Connection
Zinger, A., Cho, W. C. S., & Ben‐Yehuda, A. (2017) · Aging and Disease · doi:10.14336/ad.2016.1230 · Cited by 153
“[53] Baker DJ, Perez-Terzic C, Jin F, Pitel KS, Niederlander NJ, Jeganathan K, et al.”
BackgroundInsulin receptor endocytosis in the pathophysiology of insulin resistance
Hall, C., Yu, H., & Choi, E. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0456-3 · Cited by 159
Muscle wasting and aging: Experimental models, fatty infiltrations, and prevention
Brioche, T., Pagano, A. F., Py, G., & Chopard, A. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.04.006 · Cited by 129
“More recently, Nozaki et al. (2015) developed the C2C12 cell line from the BubR1 hypomorphic mouse model of accelerated-aging (Baker et al., 2008); these cells are characterized by a subpopulation of muscle stem cells expressing p16Ink4a (Nozaki et al., 2015).”
BackgroundDisayabutr, S., Kim, E. K., Cha, S.-I., Green, G., Naikawadi, R. P., Jones, K. D., Golden, J. A., Schroeder, A., Matthay, M. A., Kukreja, J., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0158367 · Cited by 136
“[46] Two senescence pathways have been proposed, the p53-p21-pRb pathway and the p16-pRb pathway.”
Hussain, S., Foreman, O., Perkins, S. L., Witzig, T. E., Miles, R. R., van Deursen, J., & Galardy, P. J. (2010) · Leukemia · doi:10.1038/leu.2010.138 · Cited by 145
Yang, R., Chen, J., Zhang, J., Qin, R., Wang, R., Qiu, Y., Mao, Z., Goltzman, D., & Miao, D. (2019) · Aging Cell · doi:10.1111/acel.13095 · Cited by 138
“…and reduced cell senescence, demonstrating that p16 is an effector of cellular senescence and aging, In contrast, inactivation of p19, a regulator of p53, accelerated aging in vivo and increased cell senescence, demonstrating that p19 delays aging, at least in this model (Baker et al., 2008).”
BackgroundRole of Cellular Senescence in Type II Diabetes
Narasimhan, A., Flores, R. R., Robbins, P. D., & Niedernhofer, L. J. (2021) · Endocrinology · doi:10.1210/endocr/bqab136 · Cited by 133
p21 Both Attenuates and Drives Senescence and Aging in BubR1 Progeroid Mice
Baker, D. J., Weaver, R. L., & van Deursen, J. M. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.03.028 · Cited by 130
“Analysis of Progeroid Phenotypes Biweekly checks for lordokyphosis and cataracts were as previously described (Baker et al., 2008b).”
InfluentialSelf-citationKuwahara, H., Horie, T., Ishikawa, S., Tsuda, C., Kawakami, S., Noda, Y., Kaneko, T., Tahara, S., Tachibana, T., Okabe, M., et al. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.02.011 · Cited by 136
The Fountain of Youth by Targeting Senescent Cells?
de Keizer, P. L. J. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.11.006 · Cited by 127
Murakami, T., Inagaki, N., & Kondoh, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.869414 · Cited by 144
“Earlier work observed that the aging phenotype in progeria mice with a hypomorphic mutation in BubR1, a checkpoint gene, was partly restored by p16 deletion, but not by ablation of p19, which results in inactivation of the p53/p21 pathway (34), and that genetic removal of p16-high cells has been established as an effi…”
BackgroundMaes, O. C., Sarojini, H., & Wang, E. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21834 · Cited by 132
“The CDKN2A locus has two alternative genes, p19ARF and p16INK4a; in particular, p16 has been shown to be an effector of senescence (Baker et al., 2008).”
BackgroundLipids as Regulators of Cellular Senescence
Hamsanathan, S., & Gurkar, A. U. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.796850 · Cited by 137
Regulation of cellular senescence via the FOXO 4‐p53 axis
Bourgeois, B. M. R., & Madl, T. (2018) · FEBS Letters · doi:10.1002/1873-3468.13057 · Cited by 135
Capurso, C. A., Bellanti, F., Buglio, A. L., & Vendemiale, G. (2019) · Nutrients · doi:10.3390/nu12010035 · Cited by 138
Implicating endothelial cell senescence to dysfunction in the ageing and diseased brain
Graves, S. I., & Baker, D. J. (2020) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13403 · Cited by 118
Self-citationExpression of p16INK4a prevents cancer and promotes aging in lymphocytes
Liu, Y., Johnson, S. M., Fedoriw, Y., Rogers, A. B., Yuan, H., Krishnamurthy, J., & Sharpless, N. E. (2011) · Blood · doi:10.1182/blood-2010-09-304402 · Cited by 114
Systemic DNA damage responses in aging and diseases
Ribezzo, F., Shiloh, Y., & Schumacher, B. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.12.005 · Cited by 116
“The causal role of cellular senescence in the progeroid phenotype of these animals was demonstrated by the addition of mutant p16Ink4a gene that abrogated the senescence program thus alleviating the pathology of the BurbR1 mutant mice[100].”
Cellular senescence: Its role in tumor suppression and aging
Ohtani, N., Mann, D. J., & Hara, E. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01123.x · Cited by 134
Aneuploidy in health, disease, and aging
Ricke, R. M., & van Deursen, J. M. (2013) · The Journal of Cell Biology · doi:10.1083/jcb.201301061 · Cited by 125
“Clearing of these p16-positive cells, genetically or pharmacologically, delays progeroid features (Baker et al., 2008, 2011), providing a crucial link between senescence and aging.”
InfluentialCellular senescence in the lung across the age spectrum
Parikh, P., Wicher, S., Khandalavala, K., Pabelick, C. M., Britt, R. D., & Prakash, Y. S. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00424.2018 · Cited by 112
“For example, caloric restriction to increase lifespan was found to be associated with decreased expression of a senescence marker, p16Ink4a (102), while progeroid models such as the BubR1H/H mice show increased senescent cells (11, 173).”
BackgroundPathology of mouse models of accelerated aging
Harkema, L., Youssef, S. A., & de Bruin, A. (2016) · Veterinary Pathology · doi:10.1177/0300985815625169 · Cited by 105
“Cellular senescence is proposed as a major contributing factor in skeletal muscle aging and impaired regenerative response as inactivation of p16 restores the regenerative response and attenuates premature aging in the skeletal muscle of Bub1b mice.(10) Sarcopenia has also been reported as one of the lesions in the pr…”
Boominathan, L. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9257-9 · Cited by 120
“BUBR1 has been shown to function as a negative regulator of INK4a expression [124], suggesting that p73/p63/p53miRs, by regulating BUBR1 expression, it could regulate INK4a.”
BackgroundFlores, R. R., Clauson, C. L., Cho, J., Lee, B.-C., McGowan, S. J., Baker, D. J., Niedernhofer, L. J., & Robbins, P. D. (2017) · Aging Cell · doi:10.1111/acel.12571 · Cited by 113
Self-citation2n or not 2n: Aneuploidy, polyploidy and chromosomal instability in primary and tumor cells
Zasadil, L. M., Britigan, E. M. C., & Weaver, B. A. A. (2013) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2013.02.001 · Cited by 115
Spartan deficiency causes genomic instability and progeroid phenotypes
Maskey, R. S., Kim, M. S., Baker, D. J., Childs, B. G., Malureanu, L. A., Jeganathan, K. B., Machida, Y., van Deursen, J. M., & Machida, Y. (2014) · Nature Communications · doi:10.1038/ncomms6744 · Cited by 111
“Lordokyphosis in progeroid mouse models is often associated with osteoporosis and/or muscle wasting 24, 26 .”
Self-citationAnti‐aging activity of the Ink4/Arf locus
Matheu, A., Maraver, A., Collado, M., Garcia‐Cao, I., Cañamero, M., Borras, C., Flores, J. M., Klatt, P., Viña, J., & Serrano, M. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00458.x · Cited by 94
“Regarding p19, we and others have concluded that it has an anti-aging effect (Matheu et al., 2007; Baker et al., 2008).”
BackgroundInfluentialMaehara, K., Takahashi, K., & Saitoh, S. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01318-09 · Cited by 127
Signer, R. A. J., Montecino-Rodriguez, E., Witte, O. N., & Dorshkind, K. (2008) · Genes & Development · doi:10.1101/gad.1715808 · Cited by 102
“For example, in aging skeletal muscle of hypomorphic BubR1 mice, p16 is a mediator and Arf an attenuator of senescence (Baker et al. 2008).”
BackgroundBenkafadar, N., François, F., Affortit, C., Casas, F., Ceccato, J.-C., Menardo, J., Venail, F., Malfroy-Camine, B., Puel, J., & Wang, J. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1493-6 · Cited by 110
Metadata
- Authors
- Baker, D. J., Perez-Terzic, C., Jin, F., Pitel, K. S., Niederländer, N. J., Jeganathan, K., Yamada, S., Reyes, S., Rowe, L., Hiddinga, H. J., Eberhardt, N. L., Terzic, A., & van Deursen, J. M.
- Affiliations
- Mayo Clinic (US)
- ORCID
- Venue
- Nature Cell Biology
- Published
- 2008-05-30
- Volume
- 10
- Issue
- 7
- Pages
- 825-836
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- PMC
- PMC2594014
- OpenAlex
- W1982763980
- Cited by
- 408
- References
- 50
- Citations by year
- 2026: 10 · 2025: 17 · 2024: 24 · 2023: 20 · 2022: 26 · 2021: 32 · 2020: 30 · 2019: 23 · 2018: 25 · 2017: 29 · 2016: 29 · 2015: 24 · 2014: 27 · 2013: 17 · 2012: 20
- FWCI
- 12.19
- Type
- journal article
- Language
- en
- Update notices
- erratum (2012-05-30)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Ellison Medical Foundation
- National Institutes of Health
- National Cancer Institute (R01CA096985)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- p16INK4a, p19ARF, cellular senescence, aging, tumour suppressor, skeletal muscle, adipose tissue, premature aging, checkpoint kinase 2
- MeSH terms
- Adipose Tissue, Aging, Animals, Cells, Cultured, Eye, Fibroblasts, Genotype, Humans, Male, Mice, Inbred C57BL, Neoplasms, Tissue Distribution, Biomarkers, Survival Rate, Cellular Senescence, Protein Serine-Threonine Kinases, Mice, Knockout, Muscle, Skeletal, Cell Cycle Proteins, Cyclin-Dependent Kinase Inhibitor p16, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.